NHS National framework agreement for the supply of home parenteral nutrition (HPN)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £240,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 85141210 |
| Deadline | 19 Aug 2019 |
| Contract start | 1 Apr 2020 |
| Contract end | 31 Mar 2022 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-e72a9f25-8982-4198-a5de-50eddd536ae9 |
Awards (7)
This procurement was awarded to 7 suppliers. Values shown are per-award; the notice total is £240,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ALCURA UK LIMITED shared | £240,000,000 | 13 Feb 2020 | active |
| BAXTER HEALTHCARE (HOLDINGS) LIMITED shared | £240,000,000 | 13 Feb 2020 | active |
| B BRAUN HEALTHCARE LIMITED shared | £240,000,000 | 13 Feb 2020 | active |
| CALEA UK LIMITED shared | £240,000,000 | 13 Feb 2020 | active |
| HEALTHCARE AT HOME LTD shared | £240,000,000 | 13 Feb 2020 | active |
| LLOYDS PHARMACY CLINICAL HOMECARE LIMITED shared | £240,000,000 | 13 Feb 2020 | active |
| Royal Liverpool & Broadgreen University Hospitals N H S Trus shared | £240,000,000 | 13 Feb 2020 | active |
description
NHS National framework agreement for the supply of the home parenteral nutrition & intravenous fluid for patients with severe intestinal failure
- April 2020 to 31 March 2022 with option(s) to extend for up to a total period of 24 months
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 5 May 2020 | Award (award) | · | c160a638-1f6a-41a6-a152-3de2dd665de1-357507 |
more from NHS ENGLAND
- Products for the treatment of Haemophilia A · £215,000,000 · 11 May 2023
- NHS Framework Agreement for the supply of products for the treatment of Haemophilia A · £215,000,000 · 26 Apr 2023
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin · £526,598,540 · 3 Feb 2023
- NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care · £16,000,000 · 22 Jul 2022
- National Framework Agreement for the supply of products for the management of Hereditary Angioedema · £74,500,000 · 5 Jul 2022
- NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema · £74,500,000 · 5 Jul 2022
- NHA National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B · £250,000,000 · 5 Jul 2022
- NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A · £214,000,000 · 22 Mar 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Low and Mid Tech Medicines Homecare Services · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,343,752
- Complex Domiciliary (Home) Care Service – Adults & Children and Young People (Lot 20) · NHS Dorset Integrated Care Board
- Hospice at Home (Pembrokeshire) · Hywel Dda Local University Health Board
- Patient Discharge Bridging Service · East Sussex Healthcare NHS Trust
- NHS HWE Domiciliary Care AQP - ICB Wide · NHS Hertfordshire and West Essex Integrated Care Board
- Complex Domiciliary (Home) Care Service – Adults & Children and Young People (Lot 20)/Domiciliary Care for Adults with Progressive Degenerative Conditions (Lot 21) · NHS Dorset Integrated Care Board
- Recovery and Community Resilience (RCR) - Direct Award Process C · Dorset Council
- WHPC00945 · University Hospitals of North Midlands NHS Trust · £341,279
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.